Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-23-007682)

Filing Details

Accession Number:: 0001214659-23-007682
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-22 16:30:46
Reporting Period:: 2023-05-18

Accepted Time:: 2023-05-22 16:30:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
791908	Xoma Corp	XOMA	Pharmaceutical Preparations (2834)	522154066

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1959809	Bradley Sitko	C/O Xoma Corporation 2200 Powell Street, Suite 310 Emeryville CA 94608	Chief Investment Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-19	1,000	$19.50	3,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Stock Units	Acquisiton	2023-05-18	30,200	$0.00	30,200	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,200			No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Depositary Shares - 8.375% B Cumulative Stock	2,000	Indirect	By spouse

Footnotes

Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of XOMA common stock. The PSUs vest upon XOMA's common stock achieving a specified price per share.